ASH Clinical News December 2015 | Page 110

Palliative Care In the meantime, hematologists who treat blood cancers can still glean valuable direction from studies involving solid tumor patients. “There really are not enough role models in hematology to base practice on,” Dr. Back conceded. “But in the absence of that, why not look to solid tumors for an outline of a system that can provide value? Maybe when we apply that system, it will allow us to give the most aggressive treatment, as long as the patient can manage it, but then pivot into appropriate palliative care when necessary.” One of the great success stories with palliative care in solid tumors is symptom management, Ms. Long added. The reality is patients are fairly miserable during treatment and the stress of that may play a role in the effectiveness of the therapy. “If I can focus on helping the patient feel better – better pain control, less nausea, improved appetite – and maintain his or her QOL, it allows a space for the treatment to work,” she said. “I tell patients: ‘I